newdrugapprovals.org
The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs
Cl 223Ra Cl is the structure check out yourself FDA Approves Xofigo for Advanced Prostate Cancer May 15, 2013 — The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 di…